CUREator+ is a partnership between Brandon BioCatalyst and ANDHealth. Selected by the Federal Government’s Medical Research Future Fund (MRFF) through a competitive process, CUREator+ will deliver the $50 million MRFF BioMedTech Incubator (BMTI) program to medical research and medical innovation projects with commercial potential. CUREator+ brings together the experience of the Partners and their respective MRFF Early-Stage Translation and Commercialisation Support (ESTAC) programs, CUREator and ANDHealth+.

CUREator+ is a national program focused on accelerating the research translation and commercialisation of preclinical and clinical early-stage Australian medical research and medical innovations with commercial potential. These innovations include drugs (novel and repurposed), devices, diagnostics and digital technologies that address an unmet need, demonstrate a clear clinical and commercial differentiation, and are underpinned by strong intellectual property positions. It is expected that projects applying for CUREator+ funding possess a lead asset(s)/product/technology, which has demonstrated Proof of Concept/ Proof of Principle to support their funding request.

CUREator+ will provide small-to-medium enterprises (SMEs) with access to investment capital, commercial guidance, international expert networks, and hands-on support and mentorship to drive the translation and commercialisation of their opportunities. In addition to program oversight, SMEs will be supported to secure follow-on funding and facilitate their continued development.


CUREator+ will provide funding up to a maximum of $5 million per project in two funding stages. 

Stage 1: Funding available between $1 million to $2.5 million. Funding will be provided in tranches and aligned to commercially relevant milestones. Successful projects will have up to 2 years to complete project activities and achievement of milestones, agreed as part of the application process.

Stage 2: Top-up funding will be available on a competitive basis to successful companies (maximum total of $5 million in grant funding per project from Stage 1 and 2) who meet their milestones during the Stage 1 period. Successful projects will have a maximum total of 4 years to complete Stage 1 and 2 project activities and achievement of milestones.


Funding rounds

CUREator+ Funding will be available through a competitive process and delivered in two funding rounds.

The first round is now closed for Expression of Interest (EOI) applications.

A second funding round will open in mid-2024.  Interested researchers and biotech companies will be invited to apply via:

Please refer to the funding guidelines and FAQs for further details available here.


For more information on CUREator+:

CUREator+ will host a national webinar with each funding round and encourages provide prospective applicants to book a 30-minute meeting with the CUREator+ team to discuss their opportunity.

To arrange a meeting to discuss any opportunities related to drugs, devices and diagnostics or general enquiries, please contact the CUREator team at:


To arrange a meeting to discuss any opportunity related to digital and connected health innovations or general enquiries, please contact the ANDHealth team at


You can download the FAQ’s and guidelines here.


You can watch the video of our recent webinar here.